ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP)

CUSIP: 68403P203

Q1 2020 13F Holders as of 31 Mar 2020

Holder snapshot 7 signals
Share change
+10,698
Put/Call ratio
0%
SEC-reported price per share
$3.04
Number of holders
29
Value change
-$91,414
Number of buys
11
Open additional details 1 more signal available
Number of sells
12
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
41,050,760

Security key

68403P203

Report period

Q1 2020

Institutions

29

Top holders

10

Ownership snapshot

Top reported holders of ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RENAISSANCE TECHNOLOGIES LLC
Disclosed value leader
RENAISSANCE TECHNOLOGIES LLC
Comparable rows
15/15
Latest evidence
31 Dec 2019
13F Lead comparable stake: 0.55% Showing 1-6 of 15 holder rows.

Quick read

RENAISSANCE TECHNOLOGIES LLC leads the comparable SEC ownership view at 0.55%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RENAISSANCE TECHNOLOGIES LLC's linked filing trail.
Comparable ownership Top 5
RENAISSANCE TECHNOLOGIES LLC 0.55%
MARSHALL WACE, LLP 0.28%
BlackRock Finance, Inc. 0.14%
JANE STREET GROUP, LLC 0.09%
MORGAN JESS S & CO INC 0.08%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
0.55%
$1,173,000
227,725 shares
31 Dec 2019
MARSHALL WACE, LLP
13F
Company
13F
0.28%
$586,000
113,706 shares
31 Dec 2019
BlackRock Finance, Inc.
13F
Company
13F
0.14%
$298,000
57,836 shares
31 Dec 2019
JANE STREET GROUP, LLC
13F
Company
13F
0.09%
$196,000
38,067 shares
31 Dec 2019
MORGAN JESS S & CO INC
13F
Company
13F
0.08%
$159,000
30,900 shares
31 Dec 2019
MORGAN STANLEY
13F
Company
13F
0.06%
$120,000
23,175 shares
31 Dec 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
29
Shares
624,185
Rows available
29
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders
30
Q1 2020 holders
29
Holder diff
-1
Investor Q4 2019 Shares Q1 2020 Shares Share Diff Share Chg % Q4 2019 value Q1 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .